We're lowering our price target on Bristol Myers as two key overhangs persist
- Posted on July 31, 2025
- By CNBC
- 1 Views
We're lowering our price target on Bristol Myers as two key overhangs persist
Shares were down around 5% on Thursday afternoon despite a beat-and-raise quarter.
